Literature DB >> 20056426

Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.

Ling Huang1, Anding Shi, Feng He, Xingshu Li.   

Abstract

By targeting the dual active sites of acetylcholinesterase (AChE), a new series of berberine derivatives was designed, synthesized, and evaluated as AChE inhibitors. Most of the derivatives inhibited AChE in the sub-micromolar range. Compound 8c, berberine linked with phenol by a 4-carbon spacer, showed the most potent inhibition of AChE. A kinetic study of AChE and BuChE indicated that a mix-competitive binding mode existed for these berberine derivatives. Molecular modeling studies confirmed that these hybrids target both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE. This is the first report where AChE inhibitory activity has been associated with berberine as a lead molecule. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20056426     DOI: 10.1016/j.bmc.2009.12.035

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  16 in total

Review 1.  Natural products as a source of Alzheimer's drug leads.

Authors:  Philip Williams; Analia Sorribas; Melanie-Jayne R Howes
Journal:  Nat Prod Rep       Date:  2010-11-12       Impact factor: 13.423

2.  Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats.

Authors:  Hamid Kalalian Moghaddam; Tourandokht Baluchnejadmojarad; Mehrdad Roghani; Mehdi Khaksari; Pirasteh Norouzi; Malihea Ahooie; Fatemeh Mahboobi
Journal:  Mol Neurobiol       Date:  2013-10-10       Impact factor: 5.590

Review 3.  Hybrids: a new paradigm to treat Alzheimer's disease.

Authors:  Manjinder Singh; Maninder Kaur; Navriti Chadha; Om Silakari
Journal:  Mol Divers       Date:  2015-09-02       Impact factor: 2.943

4.  Molecular basis of inhibitory activities of berberine against pathogenic enzymes in Alzheimer's disease.

Authors:  Hong-Fang Ji; Liang Shen
Journal:  ScientificWorldJournal       Date:  2012-01-04

5.  Targeting acetylcholinesterase: identification of chemical leads by high throughput screening, structure determination and molecular modeling.

Authors:  Lotta Berg; C David Andersson; Elisabet Artursson; Andreas Hörnberg; Anna-Karin Tunemalm; Anna Linusson; Fredrik Ekström
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

Review 6.  Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.

Authors:  Natalia Guzior; Anna Wieckowska; Dawid Panek; Barbara Malawska
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 7.  Building Bridges: Biocatalytic C-C-Bond Formation toward Multifunctional Products.

Authors:  Nina G Schmidt; Elisabeth Eger; Wolfgang Kroutil
Journal:  ACS Catal       Date:  2016-06-08       Impact factor: 13.084

8.  Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS.

Authors:  Cheng-Fu Chang; Yi-Chao Lee; Kuen-Haur Lee; Hui-Ching Lin; Chia-Ling Chen; Che-Kun James Shen; Chi-Chen Huang
Journal:  J Biomed Sci       Date:  2016-10-21       Impact factor: 8.410

9.  Rational design of berberine-based FtsZ inhibitors with broad-spectrum antibacterial activity.

Authors:  Ning Sun; Fung-Yi Chan; Yu-Jing Lu; Marco A C Neves; Hok-Kiu Lui; Yong Wang; Ka-Yan Chow; Kin-Fai Chan; Siu-Cheong Yan; Yun-Chung Leung; Ruben Abagyan; Tak-Hang Chan; Kwok-Yin Wong
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

10.  Inhibition of acetylcholinesterase by two genistein derivatives: kinetic analysis, molecular docking and molecular dynamics simulation.

Authors:  Jiansong Fang; Ping Wu; Ranyao Yang; Li Gao; Chao Li; Dongmei Wang; Song Wu; Ai-Lin Liu; Guan-Hua Du
Journal:  Acta Pharm Sin B       Date:  2014-11-22       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.